delta-9-tetrahydrocannabinol

URI: https://gptkb.org/entity/delta-9-tetrahydrocannabinol
GPTKB entity
Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:Cannabis
gptkb:psychoactive_compound
gptkbp:abbreviation gptkb:THC
gptkbp:aroma distinctive
gptkbp:ATCCode gptkb:N02BG10
gptkbp:boilingPoint 157°C
gptkbp:brand gptkb:Marinol
gptkb:Syndros
gptkbp:broadcastOn gptkb:Schedule_I_(US_federal_law)
gptkbp:CASNumber 1972-08-3
gptkbp:chemicalFormula C21H30O2
gptkbp:color colorless oil
gptkbp:controlledSubstanceSchedule yes
gptkbp:discoveredBy gptkb:Raphael_Mechoulam
gptkbp:discoveredIn 1964
gptkbp:effect euphoria
altered perception
analgesia
increased appetite
gptkbp:eliminationHalfLife 1.6–59 hours
gptkbp:excretion urine
feces
gptkbp:flavor gptkb:bitter
gptkbp:foundIn cannabis
gptkbp:isomerOf delta-8-tetrahydrocannabinol
gptkbp:IUPACName gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
gptkbp:legalStatus varies by country
gptkbp:meltingPoint 157°C
gptkbp:metabolism liver
gptkbp:molecularWeight 314.464 g/mol
gptkbp:overdoseSymptoms low
gptkbp:pregnancyCategory not recommended
gptkbp:PubChem_CID gptkb:ChEMBL651
16078
gptkbp:relatedTo cannabidiol
cannabinol
gptkbp:routeOfAdministration oral
inhalation
sublingual
gptkbp:sideEffect anxiety
paranoia
red eyes
dry mouth
impaired memory
gptkbp:solubility lipid-soluble
gptkbp:target gptkb:CB1_receptor
gptkb:CB2_receptor
gptkbp:UNII 7J8887I17Q
gptkbp:usedFor medical cannabis
gptkbp:bfsParent gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
gptkb:Sativex
gptkbp:bfsLayer 7
https://www.w3.org/2000/01/rdf-schema#label delta-9-tetrahydrocannabinol